We have experienced first-hand, with loved ones and ourselves, the need for new drugs to reach patients with complex illnesses. We want to help as many researchers, clinicians, innovators, and companies as possible to de-risk their R&D, accelerate clinical translation, and improve health outcomes. Our team is founded on this ideal. We see software as a creative art, where cutting-edge tools support good science for everyone’s benefit.